StonvexLoading…
StonvexStonvexStonvexCore line items from GKOS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $507.44M | $383.48M | $314.71M | $282.86M |
Operating Income | $-199.60M | $-122.37M | $-128.70M | $-82.31M |
Net Income | $-187.69M | $-146.37M | $-134.66M | $-99.19M |
EPS (Diluted) | $-3.28 | $-2.77 | $-2.78 | $-2.09 |
Total Assets | $893.49M | $974.76M | $940.41M | $1.00B |
Total Liabilities | $237.33M | $207.82M | $478.65M | $472.38M |
Cash & Equivalents | $90.81M | $169.63M | $93.47M | $119.53M |
Free Cash Flow OCF − CapEx | $-22.45M | $-67.62M | $-78.01M | $-63.35M |
Shares Outstanding | 57.51M | 56.44M | 49.12M | 47.75M |